Inogen | INGN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 1.42B 261M 2026-06
Cooper Companies USD 192.2M 75.4M 2025-12
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Globus Medical USD 157.07M 12.16M 2026-03
Inogen USD -6.06M 467K 2024-09
Insulet USD 113M 27.2M 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Orthofix International USD -2.19M 20.07M 2025-12
Philips EUR 546M 356M 2026-06
ResMed USD 496.15M 13.77M 2025-12
Steris USD 257.8M 66.6M 2025-12
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD -3.83M 222.77M 2026-03
X T L Biopharmaceuticals USD -385K 168K 2024-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12